title: [Characterization of the immune status of patients with vaccine-associated poliomyelitis].
abstract: Specific humoral immunity, total immune status and typing of HLA antigens, class 1, in loci A and B were studied in children with vaccine-associated paralytic poliomyelitis (VAPP). The immune status investigation revealed that changes in the content of serum immunoglobulins were most frequent. Out of 8 examined children, 5 children had IgA deficiency and 1 child had total variable immunodeficiency. In one case disturbances in cell-mediated immunity prevailed. Tissue typing revealed the presence of HLA A2 and B44 in 5 out of 6 examined children, which considerably exceeded their average occurrence among the Belorussian population. In spite of frequent detection of immunological disturbances in VAPP patients, out of 38 serologically examined children 36 (95%) were found to have virus-neutralizing serum antibodies to poliovirus, which was indicative of the capacity of their immune system for response to the administration of vaccine virus. To minimize the risk of VAPP in children and to achieve the goal of poliomyelitis eradication the combined immunization scheme consisting of 1-3 vaccinations with inactivated poliovaccine with subsequent administration of oral vaccine prepared from attenuated Sabin viruses is regarded as most promising.
authors.affiliation: Research Institute of Epidemiology and Microbiology, Research Institute of Hematology and Blood Transfusion, Minsk, Belarus.
authors.forename: M A
authors.initials: MA
authors.lastname: Ermolovich
authors.forename: E V
authors.initials: EV
authors.lastname: Fel'dman
authors.forename: E O
authors.initials: EO
authors.lastname: Samoĭlovich
authors.forename: N A
authors.initials: NA
authors.lastname: Kuzovkova
authors.forename: V I
authors.initials: VI
authors.lastname: Levin
mesh_terms: D000483:Alleles; D000917:Antibody Formation; D002675:Child, Preschool; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007223:Infant; D011051:Poliomyelitis / Q000209:etiology* / Q000276:immunology* / Q000635:transmission; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*; D002094:Republic of Belarus; D012189:Retrospective Studies; D014611:Vaccination / Q000009:adverse effects
chemical_list: D006680:HLA Antigens; D011055:Poliovirus Vaccine, Oral